takeda gets japanese approval for $62 billion shire purchase
reuters
takeda
pharmaceutical
co
ltd
said
on
thursday
japan
s
fair
trade
commission
had
approved
its
billion
billion
acquisition
of
shire
plc
bringing
the
japanese
firm
closer
to
sealing
a
deal
that
will
make
it
a
global
top
drugmaker
the
deal
which
will
be
the
largest
overseas
purchase
by
a
japanese
company
has
already
received
unconditional
clearance
from
regulators
in
the
united
states
brazil
and
china
takeda
is
proud
of
its
japanese
heritage
and
we
are
looking
forward
to
building
on
this
heritage
as
a
combined
company
to
continue
delivering
medicines
that
are
transformative
to
patients
in
japan
and
around
the
world
takeda
ceo
christophe
weber
said
in
a
statement
takeda
is
also
waiting
for
a
nod
from
eu
antitrust
regulators
they
are
expected
to
make
a
decision
by
but
can
open
a
long
investigation
if
they
have
serious
concerns
reporting
by
takashi
umekawa
in
tokyo
and
shashwat
awasthi
in
bengaluru
editing
by
sunil
nair
